肺间质纤维化合并肺气肿运用升陷汤加减治疗的疗效观察

Shengxian Decoction for pulmonary interstitial fibrosis complicated with emphysema

目的 观察肺间质纤维化合并肺气肿运用升陷汤加减治疗的疗效。方法 选取本院2017年1月至2019年1月收治的60例肺间质纤维化合并肺气肿患者,按照数字随机方法将其分成对照组与实验组,每组30例;对照组选择常规治疗,实验组则在常规治疗的同时,运用升陷汤加减治疗,观察比较临床疗效。结果 实验组的总有效率为93.3%,明显高于对照组的70.0%(P<0.05)。两组治疗前的肺活量(VC)、肺总量(TLC)比较差异无统计学意义(P>0.05);与治疗前相比,两组治疗后的VC、TLC均明显提高(均P<0.05),而且实验组治疗后的VC、TLC均明显高于对照组(均P<0.05)。结论 运用升陷汤加减治疗肺间质纤维化合并肺气肿患者,能取得较为理想的临床疗效,具有临床价值。

Objective To observe the therapeutic effect of Shengxian Decoction for pulmonary interstitial fibrosis complicated with emphysema. Methods 60 patients with pulmonary interstitial fibrosis complicated with emphysema admitted to our hospital from January, 2017 to January, 2019 were randomly divided into a control group and an experimental group, with 30 cases in each group. The control group was routinely treated;in addition, the experimental group was treated with Shengxian Decoction. The clinical efficacies were observed and compared. Results The total effective rate was 93.3% in the experimental group, and was 70.0% in the control group (P < 0.05). There were no statistical differences in VC and TLC between the two groups before treatment (P > 0.05). The VC and TLC were significantly higher after than before the treatment in both groups (P < 0.05), and were higher in the experimental group than in the control group (P < 0.05). Conclusion Shengxian Decoction for patients with pulmonary interstitial fibrosis and emphysema can achieve better clinical efficacy and has clinical value.